GE Healthcare Ireland Limited
2
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-04-15 to 2026-04-15
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-04-15 | FDA Drug | FDA Recall: GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthca | GE Healthcare Ireland Limited | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthca | GE Healthcare Ireland Limited | Class II | N/A |